Health
Researchers create AI system that matches tumors to best drug combinations – News-Medical.net
Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
Reviewed by Emily Henderson, B.Sc.Oct 23 2020
Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
That’s because right now we can’t match the right combination of drugs to the right patients in a smart way. And especially for cancer, where we can’t always predict which drugs will work best given the unique, complex inner workings of a person’s tumor cells.”
Trey Ideker, PhD, Professor, School of Medicine and Moores…
-
Noosa News17 hours agoHow Lily Steele-Park took her rapist to court and won
-
General23 hours agoRush to buy homes before rate cuts send prices soaring
-
Business22 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Business20 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025